Copanlisib and Gemcitabine in Relapsed/Refractory PTCL

NCT03052933 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Mature T-Cell and NK-Cell Neoplasm

Interventions

DRUG: Copanlisib
DRUG: Gemcitabine

Sponsor

Chonnam National University Hospital

Collaborators

[object Object]
[object Object]